4D MOLECULAR THERAPEUTICS IN (FDMT) Institutional Ownership and Insiders Activity

4D MOLECULAR THERAPEUTICS IN (FDMT) is widely held by institutional investors, with 150 firms reporting positions valued at approximately $737.01M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $67.16M in FDMT holdings in its latest filing.

Recent insider activity includes 17 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.